Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for the Cherokee Nation Health Service, provide an overview of COVID-19,… […]
Audience: Clinical
Navajo Area IHS COVID-19 Situation Awareness | COVID-19 Clinical Care | Gallup Indian Medical Center Facility Readiness | March 17, 2020
Dr. Vivian Huang, Area Diabetes Consultant for the Navajo Area IHS, provides a situation report on the COVID-19 pandemic nationwide. In the second, Dr. Jonathan Iralu, IHS Chief Clinical Consultant… […]
Microdose Buprenorphine Inductions | March 5, 2020
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement… […]
Read More… from Microdose Buprenorphine Inductions | March 5, 2020
Introduction to Harm Reduction | February 20, 2020
Jessica Rienstra, Hepatitis C Project Coordinator at Lummi Tribal Health Center, shares an overview of harm reduction principles and the benefits of harm reduction for both patients and providers. She… […]
Read More… from Introduction to Harm Reduction | February 20, 2020
The Gut Microbiome | February 13, 2020
Our gut bacteria are blamed for many health problems, including weight gain and diabetes. Dr. Mary Carol Greenlee, a private practitioner at Western Slope Endocrinology, examines how managing the gut… […]
Trickster Tails | February 6, 2020
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, demonstrates how traditional indigenous knowledge and stories can aid in overcoming trauma related to opioid… […]
Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares methadone, buprenorphine, and extended release naltrexone in terms of efficacy on a stable dose, induction, retention,… […]
Read More… from Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020
Diabetes Management in Patients with Renal Disease | January 9, 2020
Dr. Mary Carol Greenlee, a private practitioner at Western Slope Endocrinology in Grand Junction, Colorado, offers evidence-based suggestions for managing diabetes in patients with end-stage kidney disease. […]
Read More… from Diabetes Management in Patients with Renal Disease | January 9, 2020
Maternal Substance Use Disorders and Infant Withdrawal Syndromes in Hospital Deliveries Among American Indians/Alaska Natives | December 19, 2019
In this presentation, Dr. Chiao-Wen Lan, Dr. Tom Weiser, and Sujata Joshi from the Northwest Portland Area Indian Health Board, discuss how prenatal exposure to substances can negatively affect fetal… […]
Microdose Buprenorphine Inductions | December 5, 2019
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement… […]
Read More… from Microdose Buprenorphine Inductions | December 5, 2019
